Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.600 GeneticVariation disease UNIPROT
Entrez Id: 7248
Gene Symbol: TSC1
TSC1
0.600 GeneticVariation disease UNIPROT
Entrez Id: 2950
Gene Symbol: GSTP1
GSTP1
0.600 Biomarker disease RGD Inhibition of urinary bladder carcinogenesis by aqueous extract of sclerotia of Polyporus umbellatus fries and polyporus polysaccharide. 21213404 2011
Entrez Id: 1728
Gene Symbol: NQO1
NQO1
0.600 Therapeutic disease RGD Compared to the control group, a more preventive effect of SPUE and PPS treatment on bladder cancer was discovered, higher mRNA upregulation of GSTpi and NQO1 was seen in the treatment group. 21213404 2011
Entrez Id: 999
Gene Symbol: CDH1
CDH1
0.600 Biomarker disease RGD E-cadherin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in rats. 17167984 2006
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
0.300 Biomarker disease RGD Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers. 18712722 2008
Entrez Id: 1019
Gene Symbol: CDK4
CDK4
0.280 Biomarker disease RGD Deregulation of the p16-cyclin D1/cyclin-dependent kinase 4-retinoblastoma pathway involved in the rat bladder carcinogenesis induced by terephthalic acid-calculi. 16896691 2006
Entrez Id: 5328
Gene Symbol: PLAU
PLAU
0.250 Therapeutic disease RGD Intravesical administration of plasminogen activator inhibitor type-1 inhibits in vivo bladder tumor invasion and progression. 19010488 2009
Entrez Id: 7298
Gene Symbol: TYMS
TYMS
0.240 Biomarker disease RGD In the rat bladder cancer model, the total TS concentration and F-RNA in the tumor after the administration of UFT were 15.32 pmol/g and 0.780 ng/mg, respectively, being markedly higher than the corresponding values (1.22 pmol/g and 0.129 ng/mg) in the control normal bladder tissue. 18463958 2008
Entrez Id: 3852
Gene Symbol: KRT5
KRT5
0.230 Biomarker disease RGD Differential expression of keratin 5 gene in non-tumorigenic and tumorigenic rat bladder cell lines. 7507402 1993
Entrez Id: 6279
Gene Symbol: S100A8
S100A8
0.230 Biomarker disease RGD Expression of S100 protein family members in the pathogenesis of bladder tumors. 17970044 2007
Entrez Id: 6280
Gene Symbol: S100A9
S100A9
0.230 Biomarker disease RGD Expression of S100 protein family members in the pathogenesis of bladder tumors. 17970044 2007
Entrez Id: 6241
Gene Symbol: RRM2
RRM2
0.220 Biomarker disease RGD Cross-species comparison of orthologous gene expression in human bladder cancer and carcinogen-induced rodent models. 21139803 2010
Entrez Id: 6285
Gene Symbol: S100B
S100B
0.220 Biomarker disease RGD Expression of S100 protein family members in the pathogenesis of bladder tumors. 17970044 2007
Entrez Id: 4288
Gene Symbol: MKI67
MKI67
0.210 Biomarker disease RGD Inhibition of bladder tumour growth by sirolimus in an experimental carcinogenesis model. 20367636 2011
Entrez Id: 7428
Gene Symbol: VHL
VHL
0.210 Biomarker disease RGD Identification of differently expressed genes in chemical carcinogen-induced rat bladder cancers. 19399409 2009
Entrez Id: 11200
Gene Symbol: CHEK2
CHEK2
0.210 Therapeutic disease RGD Paeonia lactiflora Pall inhibits bladder cancer growth involving phosphorylation of Chk2 in vitro and in vivo. 21396995 2011
Entrez Id: 5245
Gene Symbol: PHB
PHB
0.200 Biomarker disease RGD All rat bladder tumors investigated and several cell lines had unexpectedly increased steady state levels of prohibitin mRNA compared with that of normal rat bladder or liver. 8062216 1994
Entrez Id: 3098
Gene Symbol: HK1
HK1
0.200 Therapeutic disease RGD Downregulations of proliferating cell nuclear antigen (PCNA), pyruvate kinase isozymes M2 (PKM2), hexokinase 1 (HXK-1), 6-phosphofructokinase (PFK-B), and cell surface glycoprotein (CD146) in bladder cancer after treatment were confirmed by Western blot analysis and validated by immunohistochemistry. 23893687 2013
Entrez Id: 4913
Gene Symbol: NTHL1
NTHL1
0.100 Biomarker disease HPO
Entrez Id: 5728
Gene Symbol: PTEN
PTEN
0.300 Biomarker disease MGD
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.300 Biomarker disease MGD
Entrez Id: 23385
Gene Symbol: NCSTN
NCSTN
0.200 Biomarker disease MGD
Entrez Id: 7248
Gene Symbol: TSC1
TSC1
0.600 GeneticVariation disease LHGDN The mutation spectrum of TSC1 in bladder cancer and functional evidence from TSC1 -gene-replacement studies in bladder tumour cells will be presented. 12773163 2003
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.600 PosttranslationalModification disease LHGDN We analyzed loss of heterozygosity in six microsatellite markers (D17S695, D17S654, D13S310, TH2, D9S747, and D9S161), p53 and K-ras mutations, and the promoter status of p14ARF and p16INK4a in the mononuclear normal blood cells, tumor, and plasma DNA of 27 bladder cancer patients. 11948103 2002